Maria Aunes

机构：AstraZeneca (Finland), AstraZeneca (Italy), AstraZeneca (Sweden) · ORCID：0000-0001-8148-063X

发表论文 9 篇 · 总被引 154 次 · h-index 5

代表论文

• Incidence of Sudden Death After Radiofrequency Ablation of the Atrioventricular Junction for Atrial Fibrillation (1997 · The American Journal of Cardiology · 被引 67)
• Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes) (2017 · Circulation · 被引 34)
• Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack (2021 · Stroke · 被引 18)
• Sensing of Atrial Fibrillation by a Dual Chamber Pacemaker : How Should Atrial Sensing Be Programmed to Ensure Adequate Mode Shifting? (2000 · Pacing and Clinical Electrophysiology · 被引 18)
• Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation (2013 · Journal of Electrocardiology · 被引 9)
• In Silico Predictions and In Vivo Results of Drug–Drug Interactions by Ketoconazole and Verapamil on AZD1305, a Combined Ion Channel Blocker and a Sensitive CYP3A4 Substrate (2016 · Clinical Pharmacology in Drug Development · 被引 5)